Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease [NA]
A completed Yale University clinical trial investigated the genetic influence on omega-3 fatty acids for treating nonalcoholic fatty liver d…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) [Phase 2]
Phase 2 trial TERPINS evaluating testosterone replacement for nonalcoholic steatohepatitis in men with hypogonadism has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) [Phase 4]
This entry reports the completion of a Phase 4 trial evaluating pioglitazone for nonalcoholic steatohepatitis (NASH) and related fatty liver…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis [Phase 2]
Phase 2 clinical trial results assessing safety and efficacy of solithromycin in nonalcoholic steatohepatitis without cirrhosis; the study h…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating whether a text messaging program can aid in the management of non-alcoholic fatty liver disease and no…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes [NA]
A clinical trial evaluating sitagliptin for non-alcoholic steatohepatitis in patients with type 2 diabetes has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection [NA]
A completed Phase II clinical trial evaluated the impact of a low-calorie diet on patients undergoing liver resection.
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) [Phase 2]
This update reports Phase 2 trial results for recombinant leptin therapy in nonalcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
A completed clinical trial evaluated the impact of bariatric surgery on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric Surgery
This clinical trial investigates the pathogenesis of non-alcoholic steatohepatitis and liver regeneration after bariatric surgery. Sponsor i…
-
CLINICAL_TRIALS research · 2016-08-08Clinical Trial Update: A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis [Phase 2]
A Phase 2 clinical trial evaluating ARI-3037MO for hepatic fat metabolism in patients with dysglycemia and hepatic steatosis (nonalcoholic s…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases [Phase 2]
Completed Phase 2 clinical trial of Emricasan (IDN-6556) in subjects with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating rimonabant for nonalcoholic steatohepatitis in patients with type 2 diabetes was terminated; no final efficacy resu…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes [Phase 3]
Phase 3 trial of rimonabant for nonalcoholic steatohepatitis in non-diabetic patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Role of Exenatide in NASH-a Pilot Study [Phase 2, Phase 3]
Clinical trial update showing a pilot Phase 2/3 study of exenatide in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Res…
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Fatty Acids, Genes and Microbiota in Fatty Liver
A completed clinical trial update investigating how fatty acids, host genes, and gut microbiota relate to fatty liver conditions, including …
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis [Phase 2]
A Phase 2 trial evaluating liraglutide for nonalcoholic steatohepatitis has completed, with updates on its efficacy and mechanism of action.
-
CLINICAL_TRIALS research · 2016-03-23Clinical Trial Update: NASH: Non-invasive Diagnostic Markers and Imaging
An update on a Maastricht University Medical Center trial evaluating non-invasive diagnostic markers and imaging for nonalcoholic fatty live…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the effects of a flaxseed supplement on biochemical factors and hepatic fibrosis in patients with nona…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of roflumilast and pioglitazone in adults with nonalcoholic steatohepatitis was terminated; res…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis [Phase 3]
Phase 3 trial in children with nonalcoholic steatohepatitis evaluating the efficacy and tolerability of DHA, choline, and vitamin E has comp…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) [NA]
This update reports the completion of a trial evaluating endoscopic ultrasound-guided TRUCUT biopsy for suspected nonalcoholic fatty liver d…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Anti-Fibrotic Effects of Losartan In Nash Evaluation Study [Phase 3]
Phase 3 study evaluating losartan for anti-fibrotic effects in nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) [Phase 2]
Phase 2 FLINT trial of obeticholic acid for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis reported results, showing hist…
-
CLINICAL_TRIALS research · 2015-08-20Clinical Trial Update: The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update evaluating a synbiotics supplement on lipid profile, liver enzymes, inflammatory markers, and hepati…